Laboratory assessment of fetomaternal hemorrhage is improved using flow cytometry

Laboratory Medicine

Volumn 38, Issue 6, 2007, Pages 365-371

  Davis, Bruce H ^a   Davis, Kathleen T ^a  

^a Trillium Diagnostics   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROCYTE ANTIGEN; HEMOGLOBIN F; MATERNAL ANTIBODY; MONOCLONAL ANTIBODY; RHESUS D ANTIBODY; RHESUS D ANTIGEN;

ALLOIMMUNITY; ANTIGENICITY; AUSTRALIA; DIAGNOSTIC ACCURACY; DOSE RESPONSE; ERYTHROCYTE; FETOMATERNAL TRANSFUSION; FETOPLACENTAL UNIT; FLOW CYTOMETRY; HUMAN; LABORATORY DIAGNOSIS; OPTIMAL DRUG DOSE; PREGNANCY; REVIEW; UNITED KINGDOM; UNITED STATES;

EID: 34249885078     PISSN: 00075027     EISSN: None     Source Type: Journal    
DOI: 10.1309/XW02UL8HNADGUVKN     Document Type: Review

References (52)

1. Sebring E, Polesky H. Fetomaternal haemorrhage: Incidence, risk factors, time of occurrence, and clinical effects. Transfusion. 1990;30:344-357.
2. Giacoia GP. Severe fetomaternal hemorrhage: A review. Obstet Gynecol Surv. 1997;52:372-380.
3. Polesky HF. Detection of fetomaternal hemorrhage: How, when, and why. Transfusion. 1991;31:288-289.
4. Kleihauer E, Braun H, Betke K. Demonstration of fetal hemoglobin in erythrocytes of a blood smear. Klin Wochenschr. 1957;35:637-638.
5. Anonymous. Statement from the consensus conference on anti-D prophylaxis. 7 and 8 April 1997. The Royal College of Physicians of Edinburgh. The Royal College of Obstetricians and Gynaecologists, UK. Vox Sanguinis. 1998;74:127-128.
6. Hartwell EA. Use of Rh immune globulin: ASCP practice parameter. American Society of Clinical Pathologists. Am J Clin Pathol. 1998;110:281-292.
7. Lee D, Contreras M, Robson S, et al. Recommendations for the use of anti-D immunoglobulin for Rh prophylaxis. Transfusion Med. 1999;9:93-97.
8. Augustson BM, Fong EA, Grey DE, et al. Postpartum anti-D: Can we safely reduce the dose? Med J Aust. 2006;184:611-613.
9. Chen JC, Davis BH, Wood B, et al. Multicenter clinical experience with flow cytometric method for fetomaternal hemorrhage detection. Cytometry. 2002;50:285-290.
10. Bromilow IM, Duguid JK. Measurement of feto-maternal haemorrhage: A comparative study of three Kleihauer techniques and two flow cytometry methods. Clin Lab Haematol. 1997;19:137-142.
11. Duckett JR, Constantine G. The Kleihauer technique: An accurate method of quantifying fetomaternal haemorrhage? Br J Obstet Gynaecol. 1997;104:845-846.
12. Emery CL, Morway LF, Chung-Park M, et al. The Kleihauer-Betke test. Clinical utility, indication, and correlation in patients with placental abruption and cocaine use. Arch Pathol Lab Med. 1995;119:1032-1037.
13. Campbell TA, Ware RE, Mason M. Detection of fetal hemoglobin in erythrocytes by flow cytometry. Ann NY Acad Sci. 1998;850:446-448.
14. Davis BH, Olsen S, Bigelow NC, et al. Detection of fetal red cells in fetomaternal hemorrhage using a fetal hemoglobin monoclonal antibody by flow cytometry. Transfusion. 1998;38:749-756.
15. Lloyd-Evans P, Guest A, Austin E, et al. Use of a phycoerythrin- conjugated anti-glycophorin A monoclonal antibody as a double label to improve the accuracy of FMH quantification by flow cytometry. Transfus Med. 1999;9:155-160.
16. Lloyd-Evans P, Kumpel BM, Bromelow I, et al. Use of a directly conjugated monoclonal anti-D (BRAD-3) for quantification of fetomaternal hemorrhage by flow cytometry. Transfusion. 1996;36:432-437.
17. Nance S, Garratty G. Application of flow cytometry to immunohematology. J Immun Meth. 1987;101:127-131.
18. Nelson M, Zarkos K, Popp H, et al. A flow-cytometric equivalent of the Kleihauer test Vox Sang. 1998;75:234-241.
19. Campbell TA, Ware RE, Mason M. Detection of hemoglobin variants in erythrocytes by flow cytometry. Cytometry. 1999;35:242-248.
20. Chen JC, Bigelow N, Davis BH. Proposed flow cytometric reference method for the determination of erythroid F-cell counts. Cytometry. 2000;42:239-246.
21. Johnson PR, Tait RC, Austin EB, et al. Flow cytometry in diagnosis and management of large fetomaternal haemorrhage. J Clin Pathol. 1995;48: 1005-1008
22. Nance SJ, Nelson JM, Arndt PA, et al. Quantitation of feral-maternal hemorrhage by flow cytometry. A simple and accurate method. Am J Clin Pathol. 1989;91:288-292.
23. Kumpel BM. Quantification of anti-D and fetomaternal hemorrhage by flow cytometry. Transfusion. 2000;40:6-9.
24. Kumpel BM. Labeling D+ RBCs for flow cytometric quantification of fetomaternal hemorrhage after the RBCs have been coated with anti-D. Transfusion. 2001;41:1059-1063.
25. Nelson M, Popp H, Horky K, et al. Development of a flow cytometric test for the detection of D-positive fetal cells after fetomaternal hemorrhage and a survey of the prevalence in D-negative women. Immunohematology. 1994;10:55-59.
26. Kumpel BM. Are weak D RBCs really immunogenic? Transfusion. 2006;46:1061-1062.
27. Schmidt P. Are weak D red blood cells really immunogenic? Transfusion. 2006;46:2029-2030.
28. Davis B, Ben-Ezra J, Bohmer R, et al. Fetal Red Cell Detection; Approved Guideline, CLSI Document. 2001. H52-A.
29. Davis BH. Diagnostic utility of red cell flow cytometric analysis. Clin Lab Med. 2001;21:829-840.
30. Breymann C, Fibach E, Visca E, et al. Induction of fetal hemoglobin synthesis with recombinant human erythropoietin in anemic patients with heterozygous beta-thalassemia during pregnancy. J Matern Fetal Med. 1999;8:1-7.
31. Chang Y, Smith K, Moore R, et al. An analysis of fetal hemoglobin variation in sickle cell disease: The relative contributions of the X-linked factor, beta-globin haplotypes, alpha-globin gene number, gender, and age. Blood. 1995;85:1111-1117.
32. Nagel RL, Vichinsky E, Shah M, et al. F reticulocyte response in sickle cell anemia treated with recombinant human erythropoietin: A double-blind study. Blood. 1993;81:9-14.
33. Craig JE, Sampietro M, Oscier DG, et al. Myelodysplastic syndrome with karyotype abnormality is associated with elevated F-cell production. Br J Haematol. 1996;93:601-605.
34. Luna-Fineman S, Shannon KM, Atwater SK, et al. Myelodysplastic and myeloproliferative disorders of childhood: A study of 167 patients. Blood. 1999;93:459-466.
35. Reinhardt D, Haase D, Schoch C, et al. Hemoglobin F in myelodysplastic syndrome. Ann Hematol. 1998;76:135-138.
36. Garner C, Tatu T, Reittie J, et al. Genetic influences on F cells and other hematologic variables: A twin heritability study. Blood. 2000;95:342-346.
37. Thein SL, Craig JE. Genetics of Hb F/F cell variance in adults and heterocellular hereditary persistence of fetal hemoglobin. Hemoglobin. 1998;22:401-414.
38. Thein SL, Reittie JE. F cells by immunofluorescent staining of erythrocyte smears. Hemoglobin. 1998;22:415-417.
39. Hoyer JD, Penz CS, Fairbanks VF, et al. Flow cytometric measurement of hemoglobin F in RBCs: Diagnostic usefulness in the distinction of hereditary persistence of fetal hemoglobin (HPFH) and hemoglobin S-hPFH from other conditions with elevated levels of hemoglobin F. Am J Clin Pathol. 2002;117:857-863.
40. Maier-Redelsperger M, de Montalembert M, Flahault A, et al. Fetal hemoglobin and F-cell responses to long-term hydroxyurea treatment in young sickle cell patients. The French Study Group on Sickle Cell Disease. Blood. 1998;91:4472-4479.
41. Paterakis GS, Thein SL, Fibach E, et al. Cross evaluation of three flow cytometric F cell counting methods performed by different laboratories. Hemoglobin. 1998;22:427-444.
42. Atweh G, Sutton M, Nassif I, et al. Sustained induction of fetal hemoglobin by pulse butyrate therapy in sickle cell disease. Blood. 1999;93:1790-1797.
43. Iyamu W, Adunyah S, Fasold H, et al. Enhancement of hemoglobin and F-cell production by targeting growth inhibition and differentiation of K562 cells with ribonucleotide reductase inhibitors (didox and trimidox) in combination with streptozotocin. Am J Hematol. 2000;63:176-183.
44. Marcus SJ, Kinney TR, Schultz WH, et al. Quantitative analysis of erythrocytes containing fetal hemoglobin (F cells) in children with sickle cell disease. Am J Hematol. 1997;54:40-46.
45. Steinberg MH. Determinants of fetal hemoglobin response to hydroxyurea. Semin Hematol. 1997;34:8-14.
46. Janssen WC, Hoffmann JJ. Evaluation of flow cytometric enumeration of foetal erythrocytes in maternal blood. Clin Lab Haematol. 2002;24:89-92.
47. Kennedy GA, Shaw R, Just S, et al. Quantification of feto-maternal haemorrhage (FMH) by flow cytometry. Anti-fetal haemoglobin labelling potentially underestimates massive FMH in comparison to labelling with anti-D. Transfus Med. 2003;13:25-33.
48. Kumpel BM. Analysis of factors affecting quantification of fetomaternal hemorrhage by flow cytometry. Transfusion. 2000;40:1376-1383.
49. David B, Bernard D, Navenot JM, et al. Flow cytometric monitoring of red blood cell chimerism after bone marrow transplantation. Transfus Med. 1999;9:209-217.
50. Lee T-H, Chafet D, Reed W, et al. Enhanced ascertainment of microchimerism with real-time qunatitative polymerase chain reaction amplification of insertion-deletion polymorphisms. Transfusion. 2006;46:1870-1878.
51. Little BH, Robson R, Roemer B, et al. Immunocytometric quantitation of foeto-maternal haemorrhage with the Abbott Cell-Dyn CD4000 haematology analyser. Clin Lab Haematol. 2005;27:21-31.
52. Mundee Y, Bigelow NC, Davis BH, et al. Simplified flow cytometric method for fetal hemoglobin containing red blood cells. Cytometry. 2000;42:389-393.